scispace - formally typeset
G

Giuseppe Ippolito

Researcher at National Institutes of Health

Publications -  720
Citations -  33136

Giuseppe Ippolito is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Tuberculosis. The author has an hindex of 75, co-authored 699 publications receiving 26268 citations. Previous affiliations of Giuseppe Ippolito include Bernhard Nocht Institute for Tropical Medicine & Istituto Superiore di Sanità.

Papers
More filters
Journal ArticleDOI

COVID-19 infection: the perspectives on immune responses.

TL;DR: The role of asymptomatic SARS-CoV-2 infected individuals in disseminating the infection remains to be defined and the conventional wisdom based on overall immunity of the infected patients cannot explain this broad spectrum in disease presentation.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

TL;DR: A case–control study of health care workers with occupational, percutaneous exposure to HIV-infected blood showed that significant risk factors for seroconversion were deep injury, injury with a device that was visibly contaminated with the source patient's blood, and a procedure inv...
Journal ArticleDOI

COVID-19, SARS and MERS: are they closely related?

TL;DR: COVID-19 seems not to be very different from SARS regarding its clinical features, however, it has a fatality rate lower than that of SARS and MERS and the possibility cannot be excluded that because of the less severe clinical picture of CO VID-19 it can spread in the community more easily than Mers and SARS.